Sonivie Ltd company information, Employees & Contact Information

Boston Scientific announces agreement to acquire SoniVie Ltd. PR Newswire

Boston Scientific completes SoniVie acquisition MassDevice

Latham & Watkins Advises Boston Scientific in Acquisition of SoniVie Ltd. Latham & Watkins LLP

Boston Scientific to acquire renal denervation technology developer SoniVie Vascular News

Boston Scientific to acquire Sonivie for up to $600M BioWorld MedTech

Boston Scientific buys Tivus system developer SoniVie in $540m deal Medical Device Network

Boston Scientific snags renal denervation developer SoniVie for $540M Fierce Biotech

Boston Scientific Agrees to Acquire Sonivie Ltd. For up to $540 Million JD Supra

Boston Scientific to acquire Israel’s SoniVie for up to $540M in push for hypertension treatment CTech

Boston Scientific agrees to buy SoniVie from Andera Partners pehub.com

Boston Scientific to acquire renal denervation company SoniVie MassDevice

Boston Scientific buys Israeli medical device co SoniVie Globes - Israel Business News

SoniVie completes enrolment in renal denervation study Clinical Trials Arena

FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System Diagnostic and Interventional Cardiology

Boston Scientific enters renal denervation market with acquisition worth up to $540M Cardiovascular Business

BSX Stock Set to Gain From the New Agreement to Acquire SoniVie Ltd. Zacks Investment Research

Boston Scientific makes second acquisition for $360M upfront The Business Journals

SoniVie Reports Major Advancements in Renal Denervation Program for Hypertension: REDUCED-1 Results, First-In-Human Data, FDA’s Crucial IDE Approval of Global THRIVE study geneonline.com

SoniVie announces successful procedure with Tivus system on first patient enrolled for REDUCED1 pilot study Vascular News

SoniVie completes enrollment in trial of ultrasound renal denervation for hypertension MassDevice

Breakthrough designations go to renal denervation devices in latest FDA batch MedTech Dive

SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology Vascular News

Study of TIVUS renal denervation system for hypertension treatment completes enrolment Vascular News

Boston Scientific to Purchase SoniVie Ltd. Medical Product Outsourcing

Boston Scientific to acquire Israel hypertension tech firm for up to $540M Worcester Business Journal

Sonivie’s TIVUS system secures breakthrough device designation for renal artery denervation BioWorld MedTech

SoniVie wins FDA breakthrough device designation for pulmonary hypertension device MassDevice

Israeli Firm SoniVie Gets FDA Approval For Hypertension Treatment NoCamels

SoniVie names Raymond W. Cohen as chairman of its Board Medical Buyer

SoniVie TIVUS System Receives FDA Breakthrough Device Designation Medical Product Outsourcing

Israeli medical device co SoniVie raises $60m Globes - Israel Business News

SoniVie completes first PAH catheter procedures Globes - Israel Business News